Jacqueline Loretan

A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis.

J. Mestan, G. Martiny-Baron, C. Schnell, 2016, Journal of medicinal chemistry.

Time Matters - In vitro Cellular Disposition Kinetics Help Rationalizing Cellular Potency Disconnects.

R. Stein, B. Faller, M. Wartmann, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues

A. Hierlemann, M. Rausch, M. Wiesmann, 2021, Frontiers in Pharmacology.

Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.

A. Ballestrero, F. Patrone, E. Moran, 2011, Bioorganic & medicinal chemistry.

Preclinical pharmacological profile of ABJ879, a novel epothilone B analog with potent and protracted anti-tumor activity

K. Altmann, T. O'reilly, M. Wartmann, 2004 .